Ren, Shengxiang
Xiong, Anwen
Yu, Jia
Wang, Xicheng
Han, Baohui
Pan, Yueyin
Zhao, Jun
Cheng, Yufeng
Hu, Sheng
Liu, Tianshu
Li, Yalun
Cheng, Ying
Feng, Jifeng
Yi, Shanyong
Gu, Shanzhi
Gao, Shegan
Luo, Yongzhong
Liu, Ying
Liu, Caigang
Duan, Huijie
Wang, Shuni
Yang, Xinfeng
Fan, Jia
Zhou, Caicun
Article History
Received: 13 September 2023
Accepted: 24 April 2024
First Online: 10 May 2024
Declarations
:
: HD, SW, and XY report being employed by Jiangsu Hengrui Pharmaceuticals Co., Ltd. All remaining authors have declared no conflict of interest.
: The study protocol was approved by institutional review boards or ethic committees at each center, and the study was conducted in accordance with the protocol, Good Clinical Practice guidelines and Declaration of Helsinki.
: Patients were required to provide written informed.